| 摘要 |
In one embodiment, a therapeutic composition containing a pentavalent antitnonial is provided. The pentavalent antimonial can be sodium stibogluconate, levamisole, ketoconazule, and pentamidine and biological equivalents of said compounds. Additionally, pentavalent antimoniala that can be used in accordance with the present invention may be any such compounds which are anti- leishmaniasis agents. The therapeutic composition of this embodiment contains an effective amount of pentavalent antimonial that can be used in treating infectious diseases. The types of diseases that can be treated with the present invention include, but are not limited to, the following: diseases associated with PTPase activity, immune deficiency, cancer, infections (such as viral infections), hepatitis B, and hepatitis C. The types of cancers that the present embodiment can be used to treat include those such as lymphoma, multiple myeloma, leukemia, melanoma, prostate cancer, breast cancer, renal cancer, bladder cancer. The therapeutic composition enhances cytokine activity, The therapeutic composition may include a cytokine, such as interferon alpha, interferon beta, interferon granulocyte/macrophage colony stimulating factor. |
